Orthocell Ltd has released a press release.
Pause in Trading
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Orthocell
- Remplir Approved to Commence Sales in US$84M Thai Market
- First US Distributors Signed for Remplirs US$1.6B market
- Regulatory Approval for Striate in US$65M Brazilian Market
- Remplir Cleared to Commence Sales in US$1.6B US Market
- Investor Presentation - US FDA 510(k) Clearance for Remplir
Later from Orthocell
- Replacement Trading Halt
- Remplir Approved to Commence Sales in US$75m Canadian Market
- 12 Distributors Signed for Remplir Covering 21 States in US
- Remplir Approved to Commence Sales in the Hong Kong Market
- Compelling Data Highlights Remplir Competitive Advantage
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell